1. Gergen PJ, McQuillan GM, Kiely M, et al. A population-based serologic survey of immunity to tetanus in the United States. N England J Med 1995;332:761–6.
2. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/tetanus.pdf . Accessed 24 Dec 2007.
3. Centers for Disease Control and Prevention. Notice to readers food and drug administration approval of an acellular pertussis vaccine for the initial four doses of the diphtheria, tetanus, and pertussis vaccination series. MMWR Morb Mortal Wkly Rep 1996;45(31):676–7.
4. Centers for Disease Control and Prevention. Notice to Readers: update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep 2001;50(10):189–90.
5. Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine. Recommendations of the advisory committee of immunization practices (ACIP) and recommendation of ACIP supported by health care infection control practices committee (HICPAC), for use of Tdap among healthcare personnel. Mortal Wkly Rep 2006;55(RR17):1–36.